Price M R, Ladányi A, Uray K, Ma Y, Sekowski M, Durrant L G
Cancer Research Laboratories, School of Pharmaceutical Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
Int J Oncol. 1999 Oct;15(4):803-9. doi: 10.3892/ijo.15.4.803.
Two monoclonal antibodies (MAb996 and MAb994) were produced by immunisation with a synthetic peptide with a sequence based upon that of the protein core of the gastrointestinal MUC2 mucin. The epitopes were identified as T G T Q for MAb996 and P T G T Q for MAb994. Antibody competition tests also confirmed the overlapping nature of the epitopes for the two antibodies. MAb994 and MAb996 were employed in immunoadsorbent columns for the fractionation of human colorectal carcinoma tissue extracts. While the two antibodies displayed only relatively minor differences in immunological specificity and affinity for the immunising synthetic MUC2 mucin core related peptide, they had the capacity to separate antigenically distinct molecules when used as immunoadsorbents. The findings indicated that subfractions of MUC2 antibody-defined mucins exist in human carcinomas and that these may be distinguished by the differential exposure of determinants in the mucin protein core. The results are in accord with the view that aberrant patterns of glycosylation of mucins in human intestinal tumours produces a spectrum of variably glycosylated macromolecules.
通过用基于胃肠道MUC2粘蛋白蛋白质核心序列的合成肽进行免疫,制备了两种单克隆抗体(MAb996和MAb994)。MAb996的表位鉴定为T G T Q,MAb994的表位鉴定为P T G T Q。抗体竞争试验也证实了这两种抗体表位的重叠性质。MAb994和MAb996被用于免疫吸附柱,以分离人结肠直肠癌组织提取物。虽然这两种抗体在免疫特异性和对免疫用合成MUC2粘蛋白核心相关肽的亲和力方面仅表现出相对较小的差异,但当用作免疫吸附剂时,它们有能力分离抗原性不同的分子。这些发现表明,人癌组织中存在MUC2抗体定义的粘蛋白亚组分,并且这些亚组分可能通过粘蛋白蛋白质核心中决定簇的不同暴露而得以区分。结果与以下观点一致,即人肠道肿瘤中粘蛋白糖基化模式异常会产生一系列糖基化程度不同的大分子。